Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer.

Nobumichi TanakaIsao AsakawaYasushi NakaiMakito MiyakeSatoshi AnaiTomomi FujiiMasatoshi HasegawaNoboru KonishiKiyohide Fujimoto

Published in: BMC cancer (2017)

The PSA value at the last follow-up of LDR-BT was significantly lower than that of IMRT, and this result was particularly marked in patients with a normal testosterone level at the last follow-up.

Keyphrases

prostate cancer
low dose
radical prostatectomy
high dose
end stage renal disease
newly diagnosed
ejection fraction
radiation therapy
squamous cell carcinoma
smoking cessation